Thrivent Financial for Lutherans
Position in GILD — Gilead Sciences, Inc.
CIK 314984
Minneapolis, MN
Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$110,786,660
-$24,681,953 QoQ
Shares Held
876,893
-9.8% QoQ
Ownership
0.071%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#134
of 2,265 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Thrivent Financial for Lutherans holds $1,673,064,906 across 14 Drug Manufacturers - General names. GILD ranks #5 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
396,540 | $475,622,010 | |
| 2 | JNJ |
Johnson & Johnson
|
1,458,722 | $370,471,625 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,340,397 | $300,741,013 | |
| 4 | AMGN |
Amgen Inc
|
494,025 | $178,896,331 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
876,893 | $110,786,660 | |
| 6 | ABBV |
AbbVie Inc.
|
391,576 | $98,536,182 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,147,117 | $66,096,880 | |
| 8 | AZN |
Astrazeneca PLC
|
282,337 | $53,536,741 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $110,786,660 | 876,893 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $135,468,613 | 972,007 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $120,166,509 | 979,033 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $108,001,668 | 972,988 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $89,547,923 | 807,684 | Shares | Sole | 2025-08-26 | |
| 2025-03-31 | $116,263,424 | 1,045,795 | Shares | Sole | 2025-08-26 | |
| 2024-12-31 | $109,612,799 | 1,186,671 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $183,395,471 | 2,187,446 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $148,153,413 | 2,159,356 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $65,717,189 | 897,163 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $117,385,189 | 1,449,021 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $113,506,895 | 1,514,637 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $123,504,904 | 1,602,503 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $132,576,516 | 1,597,885 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $161,554,416 | 1,881,822 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $113,820,516 | 1,845,040 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $55,969,942 | 905,516 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $63,527,853 | 1,068,593 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $57,165,343 | 787,293 | Shares | Sole | 2022-02-16 | |
| 2021-09-30 | $49,021,916 | 701,817 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $38,477,382 | 558,777 | Shares | Sole | 2021-09-24 | |
| 2021-03-31 | $20,661,305 | 319,686 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $21,420,162 | 367,665 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $38,262,302 | 605,512 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $44,054,382 | 572,581 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $43,722,114 | 584,833 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||